Novartis Institutes for Biomedical Research
Europe, Basel-Stadt, Switzerland, Basel
Description
Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis
Investor Profile
Novartis Institutes for Biomedical Research has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 13% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series B (50%)
- Series A (38%)
- Series C (13%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Medical Device
- Wellness
- Oncology
- Health Diagnostics
- Recruiting
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Novartis Institutes for Biomedical Research frequently co-invest with?
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Which angels does Novartis Institutes for Biomedical Research often collaborate with?
What are some of recent deals done by Novartis Institutes for Biomedical Research?
Find More Investors Like Novartis Institutes for Biomedical Research
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
